Shui‐Ping So

652 total citations
29 papers, 548 citations indexed

About

Shui‐Ping So is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Shui‐Ping So has authored 29 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pharmacology and 7 papers in Biochemistry. Recurrent topics in Shui‐Ping So's work include Receptor Mechanisms and Signaling (13 papers), Inflammatory mediators and NSAID effects (13 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Shui‐Ping So is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Inflammatory mediators and NSAID effects (13 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Shui‐Ping So collaborates with scholars based in United States and China. Shui‐Ping So's co-authors include Ke‐He Ruan, Jiaxin Wu, Hui Deng, Aimin Huang, Vanessa Cervantes, Jiaxin Wu, Jennifer Kung, Gangxiong Huang, Jiaxin Wu and Dawei Li and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Biochemistry.

In The Last Decade

Shui‐Ping So

29 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shui‐Ping So United States 16 310 183 103 66 64 29 548
Thorsten J. Maier Germany 14 247 0.8× 190 1.0× 46 0.4× 41 0.6× 93 1.5× 24 670
Steve Perry United States 13 337 1.1× 124 0.7× 36 0.3× 46 0.7× 123 1.9× 18 737
Craig H. Miller United States 13 357 1.2× 139 0.8× 56 0.5× 40 0.6× 49 0.8× 17 717
Marie‐Claude Carrière Canada 13 275 0.9× 407 2.2× 82 0.8× 58 0.9× 135 2.1× 14 927
Colleen P. Gibbons United States 4 156 0.5× 316 1.7× 41 0.4× 22 0.3× 67 1.0× 4 522
Mi Ra Chang United States 17 465 1.5× 60 0.3× 62 0.6× 28 0.4× 61 1.0× 29 993
Ralph Mosley United States 12 698 2.3× 183 1.0× 96 0.9× 24 0.4× 108 1.7× 15 1.2k
Sharon L. Wolda United States 10 1.1k 3.5× 155 0.8× 78 0.8× 117 1.8× 37 0.6× 11 1.2k
Mark Bushfield United Kingdom 17 590 1.9× 66 0.4× 194 1.9× 77 1.2× 33 0.5× 32 843
Weston Lane United States 8 491 1.6× 62 0.3× 129 1.3× 17 0.3× 76 1.2× 12 596

Countries citing papers authored by Shui‐Ping So

Since Specialization
Citations

This map shows the geographic impact of Shui‐Ping So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shui‐Ping So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shui‐Ping So more than expected).

Fields of papers citing papers by Shui‐Ping So

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shui‐Ping So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shui‐Ping So. The network helps show where Shui‐Ping So may publish in the future.

Co-authorship network of co-authors of Shui‐Ping So

This figure shows the co-authorship network connecting the top 25 collaborators of Shui‐Ping So. A scholar is included among the top collaborators of Shui‐Ping So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shui‐Ping So. Shui‐Ping So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xi, Yutao, Sheng‐an Su, Fernanda Mesquita, et al.. (2019). Abstract 17119: Substrate Stiffness Alters Human Induced Pluripotent Stem Cell-derived Cardiomyocyte Differentiation And Maturation. Circulation. 2 indexed citations
2.
So, Shui‐Ping, et al.. (2019). Novel method to detect, isolate, and culture prostate culturing circulating tumor cells. Translational Andrology and Urology. 8(6). 686–695. 3 indexed citations
3.
Li, Yan, et al.. (2019). A novel single‐chain enzyme complex with chain reaction properties rapidly producing thromboxane A2 and exhibiting powerful anti‐bleeding functions. Journal of Cellular and Molecular Medicine. 23(12). 8343–8354. 5 indexed citations
4.
So, Shui‐Ping, et al.. (2014). Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sciences. 116(1). 43–50. 56 indexed citations
5.
So, Shui‐Ping, et al.. (2012). Screening and identification of dietary oils and unsaturated fatty acids in inhibiting inflammatory prostaglandin E2 signaling in fat stromal cells. BMC Complementary and Alternative Medicine. 12(1). 143–143. 5 indexed citations
6.
Xi, Yutao, Shui‐Ping So, Jia Zhang, et al.. (2011). Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells. Journal of Cellular Physiology. 227(7). 2907–2916. 15 indexed citations
7.
So, Shui‐Ping, et al.. (2011). Novel Mechanism of the Vascular Protector Prostacyclin: Regulating MicroRNA Expression. Biochemistry. 50(10). 1691–1699. 20 indexed citations
8.
So, Shui‐Ping, et al.. (2010). Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: Mechanisms of COX-2 inhibitor risk to heart disease. Life Sciences. 88(1-2). 24–30. 63 indexed citations
9.
Ruan, Ke‐He, Vanessa Cervantes, & Shui‐Ping So. (2009). Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2. Protein Engineering Design and Selection. 22(12). 733–740. 21 indexed citations
10.
11.
Ruan, Ke‐He, Shui‐Ping So, Hanjing Wu, & Vanessa Cervantes. (2008). Large-scale expression, purification, and characterization of an engineered prostacyclin-synthesizing enzyme with therapeutic potential. Archives of Biochemistry and Biophysics. 480(1). 41–50. 7 indexed citations
12.
Ni, Feng, Shui‐Ping So, Vanessa Cervantes, & Ke‐He Ruan. (2007). A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor. FEBS Journal. 275(1). 128–137. 7 indexed citations
13.
Ruan, Ke‐He, Hui Deng, Jiaxin Wu, & Shui‐Ping So. (2005). The N-terminal membrane anchor domain of the membrane-bound prostacyclin synthase involved in the substrate presentation of the coupling reaction with cyclooxygenase. Archives of Biochemistry and Biophysics. 435(2). 372–381. 12 indexed citations
14.
Geng, Linda N., Jiaxin Wu, Shui‐Ping So, Gangxiong Huang, & Ke‐He Ruan. (2004). Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor. Archives of Biochemistry and Biophysics. 423(2). 253–265. 27 indexed citations
15.
Ruan, Ke‐He, et al.. (2004). NMR structure of the thromboxane A2 receptor ligand recognition pocket. European Journal of Biochemistry. 271(14). 3006–3016. 27 indexed citations
16.
Wu, Jiaxin, Shui‐Ping So, & Ke‐He Ruan. (2003). Determination of the membrane contact residues and solution structure of the helix F/G loop of prostaglandin I2 synthase. Archives of Biochemistry and Biophysics. 411(1). 27–35. 7 indexed citations
17.
So, Shui‐Ping, Jiaxin Wu, Gangxiong Huang, et al.. (2003). Identification of Residues Important for Ligand Binding of Thromboxane A2 Receptor in the Second Extracellular Loop Using the NMR Experiment-guided Mutagenesis Approach. Journal of Biological Chemistry. 278(13). 10922–10927. 35 indexed citations
18.
Ruan, Ke‐He, et al.. (2003). Evidence of the residues involved in ligand recognition in the second extracellular loop of the prostacyclin receptor characterized by high resolution 2D NMR techniques. Archives of Biochemistry and Biophysics. 418(1). 25–33. 15 indexed citations
19.
Wu, Jiaxin, Shui‐Ping So, & Ke‐He Ruan. (2003). Solution structure of the third extracellular loop of human thromboxane A2 receptor. Archives of Biochemistry and Biophysics. 414(2). 287–293. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thorsten J. Maier Breakdown of academic impact, for papers by Steve Perry Breakdown of academic impact, for papers by Craig H. Miller Breakdown of academic impact, for papers by Marie‐Claude Carrière Breakdown of academic impact, for papers by Colleen P. Gibbons Breakdown of academic impact, for papers by Mi Ra Chang Breakdown of academic impact, for papers by Ralph Mosley Breakdown of academic impact, for papers by Sharon L. Wolda Breakdown of academic impact, for papers by Mark Bushfield Breakdown of academic impact, for papers by Weston Lane
Rankless by CCL
2026